First, the presence or absence of immunohistochemically detectable mitochondria was validated in human kidneys and in different clinical samples of ovarian cancers using three monoclonal antibodies directed against different mitochondrial antigens, namely HSP60, fumarase and SDHA. Here, FH is linked to ovarian carcinoma.